Results 321 to 330 of about 1,678,519 (353)
Some of the next articles are maybe not open access.
Adding Azathioprine to Remission‐Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors
Arthritis & Rheumatology, 2017 X. Puéchal, C. Pagnoux, G. Baron, T. Quéméneur, A. Néel, C. Agard, F. Lifermann, E. Liozon, M. Ruivard, P. Godmer, N. Limal, A. Mékinian, T. Papo, A. Ruppert, A. Bourgarit, B. Bienvenu, L. Geffray, J. Saraux, E. Diot, B. Crestani, X. Delbrel, L. Sailler, P. Cohen, V. le Guern, B. Terrier, M. Groh, C. Le Jeunne, L. Mouthon, P. Ravaud, L. Guillevin +29 moresemanticscholar +1 more sourceClinical characteristics of and risk factors for serious infection in Japanese patients within six months of remission induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis registered in a nationwide, prospective, inception cohort study
Modern Rheumatology, 2017 Kaori Watanabe-Imai, M. Harigai, K. Sada, M. Yamamura, T. Fujii, H. Dobashi, K. Amano, S. Ito, S. Homma, S. Kumagai, S. Banno, Y. Arimura, H. Makino +12 moresemanticscholar +1 more sourceEffectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
Annals of the Rheumatic Diseases, 2016 P. Verschueren, D. De Cock, L. Corluy, R. Joos, C. Langenaken, V. Taelman, F. Raeman, I. Ravelingien, K. Vandevyvere, J. Lenaerts, E. Geens, P. Geusens, J. Vanhoof, A. Durnez, J. Remans, B. Vander Cruyssen, E. Van Essche, A. Sileghem, G. De Brabanter, J. Joly, S. Meyfroidt, K. Van der Elst, R. Westhovens +22 moresemanticscholar +1 more source
